AIM ImmunoTech Inc. AIM
0.15 USD -0.01 -4.04%
At close
0.16 0.00 +1.68%
Pre-market · Nov 2, 6:09 AM ET
- YTD
- -85.95%
- 1 year
- -92.81%
- Open
- 0.164
- Prev close
- 0.161
- Mkt cap
- 6.16M
- Vol
- 317.25K
- Avg vol
- 4.65M
- EPS
- -2.98
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1545
- High
- 0.1638
- Forward P/E
- -0.48
- Beta
- -0.36
- Short ratio
- 1.63
- Inst. own
- 14.07%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.232
- 200-d avg
- 0.338
- 1y target
- 2.75
5D chart
Chart tools
Chart is warming up
The five-day price history for AIM has not been loaded yet. Try again in a moment.
Altman Z-Score
-51.36 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 5
P/E -0.1×
P/S 20.8×
P/B -0.2×
P/FCF -0.2×
EV/EBITDA -0.4×
EV/Sales 65.8×
FCF Yield -619.7%
Gross Margin -284.1%
Operating Margin -11961.4%
Net Margin -15861.4%
ROE 142.7%
ROIC -313.6%
ROA -241.4%
Revenue -48.2%
Operating Income 46.8%
EPS (diluted) 23.2%
Free Cash Flow 24.0%
Current Ratio 0.5×
Quick Ratio 0.5×
Debt / Equity -0.5×
Net Debt / EBITDA -0.3×
Interest Coverage -13.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31